SciSparc SPRC Stock
SciSparc Price Chart
SciSparc SPRC Financial and Trading Overview
| SciSparc stock price | 1.59 USD |
| Previous Close | 0.58 USD |
| Open | 0.57 USD |
| Bid | 0 USD x 2900 |
| Ask | 0 USD x 800 |
| Day's Range | 0.55 - 0.59 USD |
| 52 Week Range | 0.4 - 2.75 USD |
| Volume | 127.35K USD |
| Avg. Volume | 361.6K USD |
| Market Cap | 4.11M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -326.4 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SPRC Valuation Measures
| Enterprise Value | 363.94K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.0548627 |
| Price/Book (mrq) | 0.60052687 |
| Enterprise Value/Revenue | 0.27 |
| Enterprise Value/EBITDA | -0.045 |
Trading Information
SciSparc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -69.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.75 USD |
| 52 Week Low | 0.4 USD |
| 50-Day Moving Average | 0.61 USD |
| 200-Day Moving Average | 0.79 USD |
SPRC Share Statistics
| Avg. Volume (3 month) | 361.6K USD |
| Avg. Daily Volume (10-Days) | 628.08K USD |
| Shares Outstanding | 7.22M |
| Float | 6.73M |
| Short Ratio | 0.65 |
| % Held by Insiders | 3.26% |
| % Held by Institutions | 4.04% |
| Shares Short | 140.57K |
| Short % of Float | 1.94% |
| Short % of Shares Outstanding | 1.94% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -192.42% |
| Operating Margin (ttm) | -615.21% |
| Gross Margin | 76.09% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -50.47% |
| Return on Equity (ttm) | -35.53% |
Income Statement
| Revenue (ttm) | 1.35M USD |
| Revenue Per Share (ttm) | 0.29 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1.03M USD |
| EBITDA | -8100000 USD |
| Net Income Avi to Common (ttm) | -2592000 USD |
| Diluted EPS (ttm) | -0.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.57M USD |
| Total Cash Per Share (mrq) | 0.52 USD |
| Total Debt (mrq) | 27K USD |
| Total Debt/Equity (mrq) | 0.42 USD |
| Current Ratio (mrq) | 1.085 |
| Book Value Per Share (mrq) | 0.949 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7917000 USD |
| Levered Free Cash Flow (ttm) | -4105375 USD |
Profile of SciSparc
| Country | United States |
| State | N/A |
| City | Tel Aviv |
| Address | Tower A |
| ZIP | 6971916 |
| Phone | 972 3 715777 |
| Website | https://scisparc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. SciSparc Ltd. has collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. The company was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Q&A For SciSparc Stock
What is a current SPRC stock price?
SciSparc SPRC stock price today per share is 1.59 USD.
How to purchase SciSparc stock?
You can buy SPRC shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SciSparc?
The stock symbol or ticker of SciSparc is SPRC.
Which industry does the SciSparc company belong to?
The SciSparc industry is Biotechnology.
How many shares does SciSparc have in circulation?
The max supply of SciSparc shares is 2.59M.
What is SciSparc Price to Earnings Ratio (PE Ratio)?
SciSparc PE Ratio is now.
What was SciSparc earnings per share over the trailing 12 months (TTM)?
SciSparc EPS is -326.4 USD over the trailing 12 months.
Which sector does the SciSparc company belong to?
The SciSparc sector is Healthcare.
SciSparc SPRC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}